ARTICLE | Company News
Bristol-Myers, Alder in ALD518 deal
November 11, 2009 1:49 AM UTC
Alder Biopharmaceuticals Inc. (Bothell, Wash.) granted Bristol-Myers Squibb Co. (NYSE:BMY) exclusive, worldwide rights to ALD518 for all indications, except cancer. The humanized mAb against IL-6 is i...